Completed PHASE1 INTERVENTIONAL 6-arm NCT01555866

Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.

A Phase 1 Open Label, 2 Part, Parallel Group Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole

Sponsor: Astellas Pharma Global Development, Inc.

Conditions Healthy Volunteers Pharmacokinetics of Isavuconazole Renal Impaired

Interventions isavuconazole

Updated 6 times since 2017 Last updated: Aug 31, 2015 Started: Mar 31, 2012 Primary completion: Apr 30, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy Volunteers and Pharmacokinetics of Isavuconazole and is currently completed. Astellas Pharma Global Development, Inc. leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Astellas Pharma Global Development, Inc.
Basilea Pharmaceutica International Ltd

Data source: Astellas Pharma Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.

Status Flow

Change History

Eligibility Summary

Contact Information

Study Locations

Related Trials